Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Metin Bagli

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Neuroreport|August 2, 2002
Cerebrospinal fluid levels of beta-amyloid(42) in patients with Alzheimer's disease are related to the exon 2 polymorphism of the cathepsin D geneAndreas Papassotiropoulos, Huw D Lewis, Metin Bagli, et al.
International Journal of Molecular Medicine|January 12, 2002
Cathepsin D: screening for new polymorphisms using single-strand conformation polymorphism analysisMicael Majores, Heike Kolsch, Metin Bagli, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 29, 2003
Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot studyMetin Bagli, Andreas Papassotiropoulos, Harald Hampel, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Neuroreport|August 2, 2002
Cerebrospinal fluid levels of beta-amyloid(42) in patients with Alzheimer's disease are related to the exon 2 polymorphism of the cathepsin D geneAndreas Papassotiropoulos, Huw D Lewis, Metin Bagli, et al.
International Journal of Molecular Medicine|January 12, 2002
Cathepsin D: screening for new polymorphisms using single-strand conformation polymorphism analysisMicael Majores, Heike Kolsch, Metin Bagli, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 29, 2003
Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot studyMetin Bagli, Andreas Papassotiropoulos, Harald Hampel, et al.
Pageof 1